Obesity treatment

Patent number:

P202130278

No items found.

The present invention shows the use of silibinin for the inhibition of pancreatic lipase, the enzyme responsible for the digestion of dietary fats. Such an effect supports the use of this compound for the prevention, improvement, alleviation and/or treatment of obesity and/or hyperlipidemia.

Countries:

Spain

Regions:

Andalusia

Region of Murcia

Centers:

UNIVERSIDAD DE GRANADA, UNIVERSIDAD CATOLICA SAN ANTONIO DE MURCIA

Other entities:

Sectors:

Health

Subsectors:

Pharmaceuticals

TRL Level:

TRL 2 – technology concept formulated

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

Treatment of obesity and hyperlipidemia. Secure administration. Lower risk of side effects. Low cost of raw material.

Comments

Other related patents

Health

ANTISEPTIC COMPOSITION CONTAINING 9-HYDROXYCALABAXANTHONE

Countries

Spain

Health

Composition comprising nanoparticles, method for the preparation of a composition comprising nanoparticles and uses of the composition for dental treatment

Countries

Spain

Health

AUXILIARY DEVICE HANDLE FOR WALKING EQUIPPED WITH PULSEXIMETER (MACHINE-TRANSLATION BY GOOGLE TRANSLATE, NOT LEGALLY BINDING)

Countries

Spain

Get back to patents directory